Liwei Wang
Xuzhou Medical College(CN)Shanghai Jiao Tong University(CN)Genmab (United States)(US)Inner Mongolia University(CN)Renji Hospital(CN)XinHua Hospital(CN)ShenZhen People’s Hospital(CN)Inner Mongolia Academy of Agricultural & Animal Husbandry Sciences(CN)Shanghai Cancer Institute(CN)Xuzhou Central Hospital(CN)Chengdu Second People's Hospital(CN)Northeastern University(CN)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Lymphoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, CAR-T cell therapy research
Most-Cited Works
- → Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction(2016)985 cited
- → Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial(2013)551 cited
- → Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response(2021)291 cited
- → Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial(2018)255 cited
- → A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation(2016)229 cited